PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment
- 9 November 2005
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 31 (6) , 1327-1334
- https://doi.org/10.1038/sj.npp.1300942
Abstract
Temporoparietal and posterior cingulate metabolism deficits characterize patients with Alzheimer's disease (AD). A H(2)(15)O resting PET scan covariance pattern, derived by using multivariate techniques, was previously shown to discriminate 17 mild AD patients from 16 healthy controls. This AD covariance pattern revealed hypoperfusion in bilateral inferior parietal lobule and cingulate; and left middle frontal, inferior frontal, precentral, and supramarginal gyri. The AD pattern also revealed hyperperfusion in bilateral insula, lingual gyri, and cuneus; left fusiform and superior occipital gyri; and right parahippocampal gyrus and pulvinar. In an independent sample of 23 outpatients with mild cognitive impairment (MCI) followed at 6-month intervals, the AD pattern score was evaluated as a predictor of cognitive decline. In this MCI sample, an H2(15)O resting PET scan was carried out at baseline. Mean duration of follow-up was 48.8 (SD 15.5) months, during which time six of 23 MCI patients converted to AD. In generalized estimating equations (GEE) analyses, controlling for age, sex, education, and baseline neuropsychological scores, increased AD pattern score was associated with greater decline in each neuropsychological test score over time (Mini Mental State Exam, Selective Reminding Test delayed recall, Animal Naming, WAIS-R digit symbol; Ps<0.01-0.001). In summary, a resting PET covariance pattern previously reported to discriminate AD patients from control subjects was applied prospectively to an independent sample of MCI patients and found to predict cognitive decline. Independent replication in larger samples is needed before clinical application can be considered.Keywords
This publication has 43 references indexed in Scilit:
- Added Clinical Benefit of Incorporating 2-Deoxy-2-[18F]Fluoro-D-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive ImpairmentMolecular Imaging & Biology, 2002
- Voxel-Based Mapping of Brain Hypometabolism in Permanent Amnesia with PETNeuroImage, 2001
- Olfactory Deficits in Patients With Mild Cognitive Impairment Predict Alzheimer’s Disease at Follow-UpAmerican Journal of Psychiatry, 2000
- Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1999
- Functional brain networks in DYT1 dystoniaAnnals of Neurology, 1998
- Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's diseaseAnnals of Neurology, 1997
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer typeJournal of Clinical and Experimental Neuropsychology, 1988
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984